Abortion pill Miffa-Pristone was given approval for use by the US Food and Drug Administration more than two decades ago. A federal judge in Texas overturned its regulatory approval, which in effect created a nationwide ban. The FT's Brook Masters argues the battle may have a chilling effect on innovation in the US.